Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiometabolic Risk Effects of Short-term Cessation of Effective Neurostimulation Therapy in OSA

NCT06720545 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06720545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06720545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiometabolic Risk Effects of Short-term Cessation of Effective Neurostimulation Therapy in OSA
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Recruiting
Start date
January 5, 2025
Completion date
January 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea, obstructive sleep apnea of adult